000 01413 a2200385 4500
005 20250516013601.0
264 0 _c20110222
008 201102s 0 0 eng d
022 _a1872-9096
024 7 _a10.1016/j.antiviral.2010.09.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDoncel, Gustavo F
245 0 0 _aPreclinical evaluation of anti-HIV microbicide products: New models and biomarkers.
_h[electronic resource]
260 _bAntiviral research
_cDec 2010
300 _aS10-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
650 0 4 _aAnti-HIV Agents
_xanalysis
650 0 4 _aAnti-Infective Agents
_xadministration & dosage
650 0 4 _aBiomarkers, Pharmacological
650 0 4 _aDosage Forms
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aDrug and Narcotic Control
650 0 4 _aEndpoint Determination
650 0 4 _aFemale
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInvestigational New Drug Application
650 0 4 _aMale
650 0 4 _aModels, Animal
650 0 4 _aTreatment Outcome
700 1 _aClark, Meredith R
773 0 _tAntiviral research
_gvol. 88 Suppl 1
_gp. S10-8
856 4 0 _uhttps://doi.org/10.1016/j.antiviral.2010.09.018
_zAvailable from publisher's website
999 _c20401989
_d20401989